Type I plus
Protein adsorption and leaching from primary glass packaging are the root causes of reduced shelf life in sensitive formulations. Metal ion leaching from type I glass leads to a pH shift in water for injectable or unbuffered solutions, which can decrease the stability or activity of biopharmaceuticals. CHARACTERISTICS SCHOTT Type I plus® vials have a silicon dioxide coating on the inside surface that has outstanding barr…
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Very cost effective.
Choronic renal dysfunction-aplasia red blood cell derived anemia
The product has been steadily demanded from clinical units and its quality is assured with its container related issue.
Review Date: 10 Feb 2020 | SCHOTT Technical Glass Solutions GmbH
Protein adsorption and leaching from primary glass packaging are the root causes of reduced shelf life in sensitive formulations. Metal ion leaching from type I glass leads to a pH shift in water for injectable or unbuffered solutions, which can decrease the stability or activity of biopharmaceuticals.
CHARACTERISTICS
SCHOTT Type I plus® vials have a silicon dioxide coating on the inside surface that has outstanding barrier properties. This reduces the interaction between drug and container surface to a bare minimum, providing a superior packaging solution for sensitive ingredients.
YOUR ADVANTAGES
- Increased shelf-life stability for sensitive drug formulations.
- Minimized adsorption of proteins in liquid formulations – also prior to lyophilization.
- Minimized adsorption of radioactive molecules.
